Final Guidance Publications for Skin Notation Profiles, 1736 [2019-01047]

Download as PDF 1736 Federal Register / Vol. 84, No. 24 / Tuesday, February 5, 2019 / Notices were reviewed and addressed where appropriate. John J. Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2019–01046 Filed 2–4–19; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket Number CDC–2019–0001, NIOSH– 323] Draft—National Occupational Research Agenda for Hearing Loss Prevention National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Request for comment. AGENCY: The National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention announces the availability of a draft NORA Agenda entitled National Occupational Research Agenda for Hearing Loss Prevention for public comment. To view the notice and related materials, visit https:// www.regulations.gov and enter CDC– 2019–0001 in the search field and click ‘‘Search.’’ SUMMARY: Table of Contents • • • • • Dates Addresses For Further Information Contact Supplementary Information Background Electronic or written comments must be received by April 8, 2019. ADDRESSES: You may submit comments, identified by CDC–2019–0001 and docket number NIOSH–323, by any of the following methods: • Federal eRulemaking Portal: https://www.regulations.gov Follow the instructions for submitting comments. • Mail: National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C–34, Cincinnati, Ohio 45226–1998. Instructions: All submissions received in response to this notice must include the agency name and docket number [CDC–2019–0001; NIOSH–323]. All relevant comments received will be posted without change to https:// www.regulations.gov, including any DATES: VerDate Sep<11>2014 17:22 Feb 04, 2019 Jkt 247001 personal information provided. For access to the docket to read background documents or comments received, go to https://www.regulations.gov. All information received in response to this notice will also be available for public examination and copying at the NIOSH Docket Office, 1150 Tusculum Avenue, Room 155, Cincinnati, OH 45226–1998. FOR FURTHER INFORMATION CONTACT: Emily Novicki (NORACoordinator@ cdc.gov), National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Mailstop E–20, 1600 Clifton Road NE, Atlanta, GA 30329, phone (404) 498– 2581 (not a toll free number). SUPPLEMENTARY INFORMATION: The National Occupational Research Agenda (NORA) is a partnership program created to stimulate innovative research and improved workplace practices. The national agenda is developed and implemented through the NORA sector and cross-sector councils. Each council develops and maintains an agenda for its sector or cross-sector. Background: The National Occupational Research Agenda for Hearing Loss Prevention is intended to identify the research, information, and actions most urgently needed to prevent occupational injuries. The National Occupational Research Agenda for Hearing Loss prevention provides a vehicle for stakeholders to describe the most relevant issues, gaps, and safety and health needs for the sector. Each NORA research agenda is meant to guide or promote high priority research efforts on a national level, conducted by various entities, including: Government, higher education, and the private sector. This is the first Hearing Loss Prevention Agenda, developed for the third decade of NORA (2016–2026). It was developed considering new information about injuries and illnesses, the state of the science, and the probability that new information and approaches will make a difference. As the steward of the NORA process, NIOSH invites comments on the draft National Occupational Research Agenda for Hearing Loss Prevention. Comments expressing support or with specific recommendations to improve the Agenda are requested. A copy of the draft Agenda is available at https:// www.regulations.gov (see Docket Number CDC–2019–0001). DEPARTMENT OF HEALTH AND HUMAN SERVICES John J. Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. John J. Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2019–01045 Filed 2–4–19; 8:45 am] [FR Doc. 2019–01047 Filed 2–4–19; 8:45 am] BILLING CODE 4163–19–P BILLING CODE 4163–19–P PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention [CDC–2015–0021; Docket Number NIOSH– 153–C] Final Guidance Publications for Skin Notation Profiles National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice of availability. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), announces the availability of the following 5 Skin Notation Profiles [DHHS (NIOSH) Publication No. 2019– 117 to 2019–121]: SUMMARY: Substance(s) Atrazine [CAS No. 1912–24–9] Catechol [CAS No. 120–80–9] Chlorinated Camphene [CAS No. 8001– 35–2] Pentachlorophenol (PCP) [CAS No. 87– 86–5] Sodium Fluoroacetate [CAS No. 62–74– 8] The final documents were published on January 11, 2019 on the CDC website. DATES: The documents may be obtained at the following link: https:// www.cdc.gov/niosh/topics/skin/skinnotation_profiles.html. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Naomi Hudson, Dr.P.H, (iuz8@cdc.gov), Robert A. Taft Laboratories, 1090 Tusculum Avenue, MS–C32, Cincinnati, OH 45226. Telephone: (513) 533–8388 (not a toll free number). On May 1, 2015, NIOSH published a request for public review in the Federal Register [80 FR 24932] of 19 draft skin notation profiles. All comments received were reviewed and addressed where appropriate. SUPPLEMENTARY INFORMATION: E:\FR\FM\05FEN1.SGM 05FEN1

Agencies

[Federal Register Volume 84, Number 24 (Tuesday, February 5, 2019)]
[Notices]
[Page 1736]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01047]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[CDC-2015-0021; Docket Number NIOSH-153-C]


Final Guidance Publications for Skin Notation Profiles

AGENCY: National Institute for Occupational Safety and Health (NIOSH) 
of the Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: The National Institute for Occupational Safety and Health 
(NIOSH) of the Centers for Disease Control and Prevention (CDC), 
announces the availability of the following 5 Skin Notation Profiles 
[DHHS (NIOSH) Publication No. 2019-117 to 2019-121]:

Substance(s)

Atrazine [CAS No. 1912-24-9]
Catechol [CAS No. 120-80-9]
Chlorinated Camphene [CAS No. 8001-35-2]
Pentachlorophenol (PCP) [CAS No. 87-86-5]
Sodium Fluoroacetate [CAS No. 62-74-8]

DATES: The final documents were published on January 11, 2019 on the 
CDC website.

ADDRESSES: The documents may be obtained at the following link: https://www.cdc.gov/niosh/topics/skin/skin-notation_profiles.html.

FOR FURTHER INFORMATION CONTACT: Naomi Hudson, Dr.P.H, (iuz8@cdc.gov), 
Robert A. Taft Laboratories, 1090 Tusculum Avenue, MS-C32, Cincinnati, 
OH 45226. Telephone: (513) 533-8388 (not a toll free number).

SUPPLEMENTARY INFORMATION: On May 1, 2015, NIOSH published a request 
for public review in the Federal Register [80 FR 24932] of 19 draft 
skin notation profiles. All comments received were reviewed and 
addressed where appropriate.

John J. Howard,
Director, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention.
[FR Doc. 2019-01047 Filed 2-4-19; 8:45 am]
 BILLING CODE 4163-19-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.